Medroxalol (hydrochloride)

• UNSPSC Description:

  Medroxalol hydrochloride is an orally active adrenergic receptor antagonist, blocks α- and β-adrenergic receptors. Medroxalol hydrochloride shows antihypertensive and vasodilating effects[1].

• Target Antigen:

  Adrenergic Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/medroxalol-hydrochloride.html

• Smiles:

  O=C(C1=CC(C(CNC(CCC2=CC=C3OCOC3=C2)C)O)=CC=C1O)N.Cl

• Molecular Weight:

  408.88

• References & Citations:

  [1]Dage RC, et al. Cardiovascular properties of medroxalol, a new antihypertensive drug. J Cardiovasc Pharmacol. 1981 Mar-Apr;3(2):299-315.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  70161-10-3